Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials

Overview

Sākumlapa. Informējam, ka no 1. septembra Gulbenes paraugu pieņemšanas kabinetā klientu pieņemšana būs pieejama vienu dienu nedēļā – otrdienās no plkst. 9.00 līdz 14.00. Aicinām izmantot arī citus BIOR paraugu pieņemšanas kabinetus.

News

News Nasdaq 4 years ago
Athyrium Opportunities 2020 Increases Position in Biora Therapeutics (BIOR)
Fintel reports that Athyrium Opportunities 2020 LP has filed a 13D/A form with the SEC disclosing ownership of 71,136,069 shares of Biora Therapeutics Inc (BIOR). This represents 28.4% of the company.
Read more
Report
News Nasdaq 6 years ago
Market Activity Read more
Report